Bausch + Lomb tops Q2 expectations, raises full-year guidance

Published 30/07/2025, 12:20
Bausch + Lomb tops Q2 expectations, raises full-year guidance

Investing.com -- Bausch + Lomb Corporation (NYSE/TSX:BLCO) on Wednesday reported second-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $0.07 beating estimates by $0.01 and revenue of $1.29 billion surpassing the consensus of $1.26 billion.

The company’s shares edged up 0.07% following the announcement.

The global eye health company posted a 5% increase in total revenue compared to the same quarter last year, or 3% growth on a constant currency basis.

This growth came despite challenges from the voluntary recall of enVista intraocular lenses.

The company reported a GAAP net loss of $62 million, or -$0.18 per share, an improvement from the -$0.43 per share loss in the second quarter of 2024.

Vision Care, the company’s largest segment, drove performance with revenue of $753 million, up 8% year-over-year, or 6% on a constant currency basis.

The growth was fueled by strong sales in the dry eye portfolio and contact lens business.

"Our continued growth speaks to the breadth and depth of our portfolio and is driven by a mix of hero products and a steady stream of new introductions around the world," said Brent Saunders, chairman and CEO of Bausch + Lomb.

Following the solid quarterly performance, the company raised its full-year 2025 guidance, now projecting revenue between $5.05 billion and $5.15 billion, above the analyst consensus of $5.03 billion.

This represents approximately 5-7% growth on a constant currency basis.

The company also increased its adjusted EBITDA guidance excluding acquired IPR&D to between $860 million and $910 million.

The company highlighted several achievements, including resuming full production of all enVista platform IOLs following their return to market and reaching approximately $1 billion in trailing 12-month revenue across its dry eye portfolio.

Cash flow from operations improved to $35 million for the quarter, up from $15 million in the same period last year, primarily due to improvements in working capital.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.